Allergan news releases. , was appointed to Tarsus Pharmaceuticals' Board of Directors. , Feb /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that it has completed its acquisition of Allergan plc FDA News Release FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. S. /PRNewswire/ -- Allergan Aesthetics, an AbbVie (NYSE: ABBV) Company, announces Moving the Needle on Ethics- its collaboration with medical aesthetics experts Statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Allergan's current perspective of existing trends –Data results shared across facial injectables, body contouring and skincare portfolio highlights Allergan Aesthetics' continued commitment to advancing Following the agency's request, Allergan has notified the FDA that it is moving forward with a worldwide recall of their BIOCELL textured breast implant products, including: Natrelle Saline-Filled . Read Press Release for Tarsus Pharmaceuticals (TARS) published on Feb. Allergan plc: News, information and stories for Allergan plc | Nyse: AGN | Nyse Statements contained in this press release that refer to future events or other non-historical facts, including with respect to Allergan's acquisition of LifeCell are forward-looking statements FDA issued warning letters to two breast implant manufacturers for failure to comply with various regulatory requirements. and Allergan plc have agreed to divest assets to settle Federal Trade Commission charges that AbbVie’s proposed $63 billion acquisition of Allergan would violate federal antitrust law. Allergan is a global pharmaceutical company and a leader in a new industry model – Growth Pharma. Nov 12, 2025 · Allergan Aesthetics Continues Its Mission of Empowering Women Through the Faces of Natrelle® Testimonial Program The nationwide program invites eligible Natrelle® breast augmentation and reconstruction patients to share their personal experiences. Department of Treasury on April 4, 2016, which the companies concluded qualified as an “Adverse Tax Law Change” under the merger Question: Exhibit 1 presents the fourth quarter press release of Allergan. Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. 24, 2025 - Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025 The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year Allergan Aesthetics gives patients exciting BOTOX® Cosmetic offers only in the Allē app Buy one $50 gift card, get one free, plus, register, book a consultation, and get treated for a chance to win Tue, Oct 28, 2025 Press Releases Strategic Press Release Marketing Expands Local Brand Visibility in 2026 NEW ORLEANS, LA, UNITED STATES, February 18, 2026 /EINPresswire. ALLODERM SELECTTM RTM and ALLODERM SELECT RESTORETM RTM are processed by LifeCell Corporation, One Millennium Way, Branchburg, NJ 08876 USA. Nov 12, 2025 · The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year Allergan Aesthetics gives patients exciting BOTOX® Cosmetic offers only in the Allē app Buy one $50 gift card, get one free, plus, register, book a consultation, and get treated for a chance to win Tue, Oct 28, 2025 Press Releases 2 days ago · Allergan Aesthetics Continues Its Mission of Empowering Women Through the Faces of Natrelle® Testimonial Program The nationwide program invites eligible Natrelle® breast augmentation and reconstruction patients to share their personal experiences. /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is initiating a new digital campaign to improve device tracking and further identify and Pharmaceutical companies AbbVie Inc. 800. I. com/ -- In 2026, press release marketing continues to evolve as a structured communication strategy that supports local brand visibility, search indexing, and long-term digital … Jan 28, 2026 · Allergan Aesthetics will showcase data across its facial injectable portfolio and pipeline through a series of posters at IMCAS 2026 underscoring its leadership in evidence-based facial aesthetics. PRODUCT ORDERING To order directly or for product information, please contact your local Allergan representative or the Allergan Customer Care Department at 1. These press releases remain on AbbVie's website for historical purposes only. Natrelle® champions women's voices to provide support at Find the latest press releases and official documents published by Allergan plc on MarketScreener. Pyott, a distinguished leader in the global biopharmaceutical industry and former Chairman and CEO of Allergan, Inc. In Allergan’s Core Study, there was a MRI screening cohort who had regular MRIs to screen for breast implant rupture whether or not they were symptomatic (i. n holds Canadian CT In order to verify receipt of actual BOTOX product from Allergan, look for a tamper-evident seal that contains a translucent silver Allergan logo on the top and bottom flaps of the BOTOX cartons, and a holographic film on the vial label. , MRI cohort) and a non-MRI screening cohort who were not screened with breast implant MRIs (i. AbbVie is stumping up more Former Allergan CEO David Pyott, who grew sales from about $1B to over $7B, joins Tarsus' board as it scales XDEMVY and advances its eye-care pipeline. Allergan has prepared this brochure to provide you with a high-level overview of the facts about breast implant surgery with Allergan’s FDA-Approved NATRELLE ® Silicone-Filled Breast Implants and NATRELLE INSPIRA® Breast Implants with smooth surface. , non-MRI cohort). About Allergan Aesthetics At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Settlement Date for AVT06, a Proposed Biosimilar to Eylea® February 17, 2026 IRVINE, Calif. com/ -- In 2026, press release marketing continues to evolve as a structured communication strategy that supports local brand visibility, search indexing, and long-term digital … Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. , to its Board of Directors. The words "believe," "expect," "anticipate," "project" and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. In Allergan’s Pivotal Study through 10 years, approximately 9 out of 10 women undergoing primary augmentation or revision-augmentation with NATRELLE® 410 Breast Implants who responded to the questi INFORMATION FOR THE USER ALLERGAN® BOTOX 100 Allergan Units, Powder for Solution for Injection Botulinum toxin type A because it contain important information for you. The decision was driven by the actions announced by the U. News from allergan plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health --AbbVie, a research-based global biopharmaceutical company, announced today that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government New AA (Allergan Aesthetics) Signature Program provides a personalized approach to treatment planning, in combination with Allergan Aesthetics' advanced facial portfolio to address patient needs and treat different areas of the face Expert led Allergan Medical Institute (AMI) symposium will US drugmaker AbbVie has agreed to buy struggling Allergan in a $63 billion deal that continues a slew of multibillion dollar takeovers in the biopharma sector this year. Its commitment to evolve is reflected in its scientific methodology; the cohort of physicians chosen as principal investigators; and the group of subjects recruited For clinical/medical questions, please contact Medical Information at IR-Medcom@allergan. com or call 1-800-678-1605, Option 2. 9 billion in cash. · GlobeNewswire Inc. AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all David E. By making its clinical trials as inclusive as possible, Allergan Aesthetics has sent a clear messag to the entire industry. Pyott, who grew Allergan’s revenue from $1 billion to $7 billion, brings extensive experience to Tarsus as it commercializes its first FDA-approved product. 0171. Forward-Looking Statements Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. (NASDAQ: TARS) today announced the appointment of David E. 18, 2026 - Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors Press Releases December 19, 2025 Alvotech and Teva Secure U. Statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Actavis' current perspective of existing trends and Statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Allergan's current perspective on existing trends The information in the press releases on these pages was factually accurate on the date of publication. Y. , Feb. Amplified Representation by Allergan Aesthetics. “David is Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Allergan relies on the surgeon to know and follow proper surgical procedures specific to the type of expansion performed to minimize the occurrence of adverse reactions. e. mentation patients are satisfied with the results of their surgery. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. , April 6 - Pfizer Inc. Allergan plc Forward-Looking Statements Statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Allergan's current perspective on existing trends and information as of the date of this release. Sep 12, 2022 · The latest international Allergan Inc news and views from Reuters - one of the world's largest news agencies Allergan, headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and Tarsus Pharmaceuticals appointed former Allergan CEO David Pyott to its board as Chairperson of the Commercial Committee. Pyott, former Chairman and CEO of Allergan, Inc. The sale and distribution of this device is restricted to users and/or facilities that provide information to patients about the risks and benefits of this device in the form and manner specified in the approved labeling provided by Allergan. The Allergan directors accept responsibility for the information contained in this report. (NYSE: PFE) today announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies. 766. Allergan’s product lines include Botox, Juvederm, Latisse, Namenda, and Restasis. IRVINE, Calif. Allergan plc: News, information and stories for Allergan plc | Nyse: AGN | Nyse Allergan plc (NYSE: AGN) ("Allergan") announced that AbbVie has now completed the acquisition of Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act 2014 (the "Scheme"), which became effective earlier today, May 8, 2020. --Allergan Aesthetics, an AbbVie company, the industry leader in aesthetics globally, continues to innovate and elevate the patient journey with the launch of its new AA Signature Program at the The latest international Allergan Inc news and views from Reuters - one of the world's largest news agencies Read Press Release for Abbvie (ABBV) published on Mar. Food and Drug Administration (FDA) for RESTASIS MULTIDOSE™ Allergan plc (AGN) announced that it has signed a definitive agreement to acquire LifeCell, the regenerative medicine unit of Texas-based privately held company Acelity for $2. /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that it has received approval from the U. Allergan plc announced that AbbVie has now completed the acquisition of Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Allergan's current perspective of existing trends /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, the industry leader in aesthetics globally, demonstrates how to elevate the patient experience and NEW YORK, N. Natrelle® champions women's voices to provide support at 2 days ago · Strategic Press Release Marketing Expands Local Brand Visibility in 2026 NEW ORLEANS, LA, UNITED STATES, February 18, 2026 /EINPresswire. jpmyrn, iigk, 2efd, mc252j, 4jknbj, agvcb, 4y0yl, hdd0, tq3e, adumv9,